India must build its own agile biopharma innovation model: ICMR DG Dr Rajiv Bahl
At India Pharma 2026, Dr Bahl calls for experimentation over imitation as funding rises and translational ecosystem reforms gather pace
At India Pharma 2026, Dr Bahl calls for experimentation over imitation as funding rises and translational ecosystem reforms gather pace
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
Integrated multidisciplinary model positions Hyderabad as a growing referral hub for advanced pediatric care
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
The company says the platform offers improved manufacturability and functional advantages
The solution integrates key molecular cloning methods—including Golden Gate, Gibson assembly, and restriction/ligation—alongside primer design, Sanger sequencing analysis, and protein translation in a single application
Subscribe To Our Newsletter & Stay Updated